Here, we use two types of E2F3-activated tumors, retinoblastoma and bladder cancer, to demonstrate that RBAT1 upregulation contributed to the activation of E2F3 in these tumor cells. This evidence concerns the gene E2F3-IT1 and urinary bladder carcinoma.